Imaging selection for acute stroke intervention

BCV Campbell; MW Parsons

Journal article

Imaging selection for acute stroke intervention

BCV Campbell, MW Parsons

International Journal of Stroke | SAGE PUBLICATIONS LTD | Published : 2018

DOI: 10.1177/1747493018765235

Abstract

This review summarizes the current state of knowledge regarding the use of imaging to guide stroke treatment. Brain imaging plays a central role in the diagnosis of stroke and identification of the mechanism of stroke, which is relevant to acute treatment, prognosis, and secondary prevention. The chief potential modalities are computed tomography (CT) and magnetic resonance imaging (MRI). Currently, most imaging occurs in hospital but mobile stroke units have expanded CT brain imaging into the prehospital field. The proven therapies for ischemic stroke are based on achieving reperfusion and the DAWN and DEFUSE 3 trials have now firmly established a need for imaging selection based on estimat..

View full abstract

University of Melbourne Researchers

Bruce Campbell Author

Mark Parsons Author

Related Projects (4)

TENECTEPLASE VERSUS ALTEPLASE FOR STROKE THROMBOLYSIS EVALUATION (TASTE) TRIAL

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) is an Australian-led international randomised trial designed to gen..

EXTEND-IA randomized trial of intra-arterial clot retrieval in ischemic stroke

Most strokes are caused by a blocked blood vessel in the brain. Current treatments to dissolve the blockage improve recovery for many patien..

STROKE IMAGING - IMPROVING PATIENT SELECTION FOR TREATMENT

Stroke is a major cause of death and disability in our community and is most often due to a blocked blood vessel. Powerful treatments are av..

SAVING BRAIN AND CHANGING PRACTICE IN STROKE

Stroke outcomes directly relate to brain tissue rescue. We have contributed to changes in clinical practice through many clinical trials of ..

Grants

Awarded by Medtronic

Funding Acknowledgements

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr Campbell reports research support from the National Health and Medical Research Council of Australia (GNT1043242, GNT1035688), Royal Australasian College of Physicians, Royal Melbourne Hospital Foundation, National Heart Foundation, National Stroke Foundation of Australia and unrestricted grant funding for the EXTEND-IA trial to the Florey Institute of Neuroscience and Mental Health from Covidien (Medtronic). Dr Parsons reports research support from the National Health and Medical Research Council of Australia (ID 1113352, ID 1079696), and National Heart Foundation of Australia.